Cipla to buy control of South Africa's Cipla Medpro
JOHANNESBURG (Reuters) - Indian drugs maker Cipla Limited (CIPL.NS) has offered to buy a about a 51 percent stake in South African drug maker Cipla Medpro CMPJ.J, Cipla Medpro said in a statement on Wednesday.
The Indian firm has offered 8.55 rand per share, Cipla Medpro said. Shares of Cipla Medpro surged on the news.
(Reporting by Helen Nyambura-Mwaura; editing by David Dolan)
NEW YORK - U.S. stocks finished mostly flat on Thursday as investors paused after a rally in the previous session, though the Dow closed at its second record high in a row. | Video
WASHINGTON - Start-up companies will be able to raise much more capital through certain public stock deals without facing costly regulatory burdens under a proposal announced by U.S. securities regulators on Wednesday.
BEIJING/HONG KONG - China reiterated its opposition on Thursday to a European Union plan to limit airline carbon dioxide emissions and called for talks to resolve the issue a day after its major airlines refused to pay any carbon costs under the new law.